You are here

China biotech taps Big Data as next weapon against cancer

Entrepreneurs and scientists are also aiming to dominate the market for complex new procedures

Hong Kong

WHEN Nisa Leung was pregnant with her first child in 2012, her doctor in Hong Kong offered her a choice. She could take a prenatal test that would require inserting a needle into her uterus, or pay US$130 more for an exam that would draw a little blood from her arm.


BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to